Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
03/2005
03/23/2005EP1516621A2 Use of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of cell proliferation diseases
03/23/2005EP1515955A2 Chemical process
03/23/2005EP1515952A2 Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1597672A Substituierte benzoylcyclohexandione
03/23/2005CN1597668A Biamido heterocyclic derivative with antitumour activity and its preparation method and use
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/17/2005WO2005023776A1 Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives
03/17/2005WO2005023775A1 Pesticides
03/17/2005WO2005023774A1 Process for the preparation of a trifluoromethylthioether
03/17/2005WO2005023773A1 Process for the preparation of substituted aryl pyrazoles
03/17/2005WO2005023731A2 Method for forming a carbon-carbon or carbon-heteroatom bond
03/17/2005WO2005023260A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005WO2005023247A1 Compounds and methods
03/17/2005WO2005000820A3 4-cyanopyrazole-3-carboxamide derivatives preparation and application thereof as cb1 cannabinoid antagonists
03/17/2005WO2004073642A3 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii and somatostatin 5 receptor ligands
03/17/2005US20050059826 Agonists, antagonists or inverse agonists for brain receptors; anxiolytics, antidepressants; nervous system, sleep and psychological disorders; Down syndrome, cognition activators
03/17/2005US20050059810 Dibenzylamine compound and medicinal use thereof
03/17/2005US20050059722 Kinase inhibitors, such as focal adhesion kinase (FAK) inhibitors; treating cancer; 2-methylsulfonyl-N-(3-thiophen-2-yl-1H-indazol-5-yl)benzenesulfonamide for example
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050058635 Anticancer agents; therapy for infections; administering glutaminyl cyclase inhibitor; Alzheimer's disease; Down syndrome; controlling fertility; schizophrenia; skin disorders
03/17/2005CA2537292A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/16/2005EP1513829A2 Nicotinoyl derivatives as herbicidal compounds
03/16/2005EP1513817A1 1, 2-azole derivatives with hypoglycemic and hypolipidemic activity
03/16/2005EP1513802A1 Alpha-sulfonylamino-acetonitriles
03/16/2005EP1513796A2 Phenyloxyalkanoic acid derivatives as hppar activators
03/16/2005EP1272472B1 1h-pyrazole derivatives, method for the production thereof and their use for inhibiting and controlling nitrification
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1594297A Process for synthesis of lonidamine
03/16/2005CN1594296A Process for preparing 4-[3-trifluoromethyl-5-(p-tolyl)-1H-pyrazolyl] benzene sulfonamide
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005CA2146852C New substituted pyrazole derivatives, processes for their preparation and their use as herbicides
03/10/2005WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
03/10/2005WO2005021490A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES
03/10/2005WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2005007620A3 New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates
03/10/2005WO2004096795A3 C-fms kinase inhibitors
03/10/2005US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
03/10/2005US20050054700 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
03/10/2005US20050054680 Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/10/2005US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
03/10/2005CA2537123A1 New compounds
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1511385A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1592742A Neurotensin active 2, 3-diaryl-pyrazolidine derivatives
03/09/2005CN1192023C Method for preparing 1-alkyl-pyrazol-5-carboxylic acid esters III
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864373 Stable amorphous celecoxib composite and process therefor
03/08/2005US6863838 Low melting point
03/03/2005WO2005019182A1 Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
03/03/2005WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase
03/03/2005WO2005019147A2 Pesticidally active phenol derivatives
03/03/2005WO2005018568A2 Inhibitors of cathepsin s
03/03/2005WO2005003098B1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents
03/03/2005WO2005000309A3 Chemical compounds
03/03/2005WO2004094370A3 Antibacterial pyrazole carboxylic acid hydrazides
03/03/2005WO2004063166A8 Heterocyclic ppar modulators
03/03/2005US20050049288 5-MEMBERED HETEROCYCLE-BASED p38 KINASE INHIBITORS
03/03/2005US20050049237 Pyrazole-amides and -sulfonamides
03/03/2005CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase
03/02/2005EP1510516A1 Pyrazole compound and medicinal composition containing the same
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1509574A1 Yellow anionic disazo dyes
03/02/2005EP1509537A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
03/02/2005EP1509505A2 SMALL MOLECULE MODULATORS OF THE 5−HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO
03/02/2005EP1509502A1 Method of forming a carbon-carbon or carbon-heteroatom linkage
03/02/2005EP1509501A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005EP1509491A1 Intermediate products, methods for their preparation and use thereof
03/02/2005EP1509216A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
03/02/2005EP1384476B1 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
03/02/2005CN1589269A Heteroindanes: a new class of potent cannabimimetic ligands
03/02/2005CN1191239C Pyrazole derivatives for the treatment of viral diseases
03/02/2005CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
03/01/2005US6861162 Organic electroluminescence devices using pyrazolo[3,4b]quinoxaline derivatives
02/2005
02/24/2005WO2005016933A1 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide
02/24/2005WO2005016892A1 Gabanergic modulators
02/24/2005WO2005016890A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
02/24/2005WO2005016877A2 Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
02/24/2005WO2005016873A2 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives
02/24/2005WO2005016870A1 2-substituted benzoic acid derivatives as hm74a receptor agonists
02/24/2005WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof
02/24/2005WO2005016344A1 Piperazine derivatives for the treatment of hiv infections
02/24/2005WO2005016277A2 Arylsulfonamidobenzylic compounds
02/24/2005WO2005016264A2 Diamine derivatives of quinone and uses thereof
02/24/2005WO2005005393A3 Cck-1 receptor modulators
02/24/2005US20050043381 Aminopyrazole compounds
02/24/2005US20050043368 Osteoporosis therapy; bone disorders
02/24/2005US20050043356 Polymorphic form of rimonabant method for preparing it and pharmaceutical compositions containing it
02/24/2005US20050043300 Piperazine derivatives
02/24/2005DE10336570A1 New pyrazolidine-1,2-dicarboxamide derivatives, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or tumors
02/24/2005CA2743534A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
02/24/2005CA2535868A1 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide
02/24/2005CA2535665A1 Substituted arylalkanoic acid derivative and use thereof
1 ... 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 ... 256